Terns Pharmaceuticals

company

Funding Rounds

Number of Funding Rounds
Total Funding Amount
6
$475.80M 
Terns Pharmaceuticals has raised a total of $475.80M  in funding over 2 rounds. Their latest funding was raised on Dec 20, 2022 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 20, 2022 Post-IPO Equity $86.30M Detail
Aug 12, 2022 Post-IPO Equity $65M 2 Fairmount Funds Management ,
Venrock Healthcare Capital Partners
Detail
Feb 4, 2021 IPO $127.50M Detail
Jan 5, 2021 Series C $87M 7 Deepfield ,
Eli Lilly
Detail
Oct 30, 2018 Series B $80M 4 OrbiMed ,
Vivo Capital
Detail
Apr 4, 2018 Series A $30M 1 Lilly Asia Ventures Detail